Page 78 - Advances in Textile Biotechnology
P. 78

Smart materials containing enzymes or enzyme substrates   57


            unwanted properties, such as toxicity or bad taste, at least before the target
            environment is reached (Jain, 1989, Risch and Reineccius, 1995, Pothaka-
            mury and BarbosaCanovas, 1995, Poznansky and Juliano, 1984, Tomlinson,
            1987, Vingerhoeds et al., 1994). Finally, a sustained or triggered release may
            be required. Therefore, a polymer, whether natural or synthetic, is judi-
            ciously combined with a drug or other active agent in such a way that the
            active agent is released from the material in a predesigned manner.
              Drug delivery and controlled release are of particular interest in cancer
            therapy and the treatment of many endocrinological disorders (Cox, 1993).
            For drug release, providing control over drug delivery can be the most
            important factor at times when traditional oral or injectable drug formula-
            tions cannot be used. A more effective therapy can be achieved while the
            risk for both under- and overdosing can be reduced. Other advantages of
            using controlled-delivery systems can include the maintenance of drug
            levels within a desired range, the need for fewer administrations, optimal
            use of the drug in question, and increased patient compliance. The ideal
            drug delivery system should be inert, biocompatible, mechanically strong,
            comfortable for the patient, capable of achieving high drug loading, safe
            from accidental release, simple to administer and remove, and easy to fab-
            ricate and sterilize.


              The field of controlled release, however, finds increasing application also
            in cosmetics and household materials (e.g. Joshi, 1996, Schaeffer and Brooks,
            1992, Withenshaw, 1996), food (Risch and Reineccius, 1995, Yolles, 1973),
            agrochemicals/crop protectants (e.g. Allan and Neogi, 1971, Cohen et al.,
            1977, Knight et al., 1995, Kuderna and Saliman, 1974, Ventakraman, 2000),
            fertilizers (e.g., Fersch and Stearns, 1976, Knight et al., 1995) and industrial
            and other reactants.
              In recent years, controlled drug delivery formulations and the polymers
            used in these systems have become very sophisticated. Carrier systems
            have been developed including particulate systems like nano- and micro-
            capsules, nano- and microspheres and liposomes (Amidon, 1997, Brannon-
            Peppas, 1995, Cox, 1993, Felgner, 2009, Risch and Reineccius, 1995).
            Materials used for these systems normally consist of natural or synthetic
            biocompatible polymers. These can be proteins, such as gelatin, albumin,

            casein, or fibrin (Banga, 1995, Bissery et al., 1984, Chen et al., 2009, Gupta
            and Hung, 1989, Narayani and Rao, 1996, Senderoff et al., 1991, Wolkoff,
            1987, Yu et al., 1996). The release of the active agent may be constant over
            a long period, it may be cyclic over a long period, or it may be triggered by
            the environment or other external events such as pH, ionic strength, ultra-
            sound or by enzymes.
              In the following we will discuss the construction, function and application
            of smart materials based on the display of enzyme activity or response to
            trigger enzymes.




                              © Woodhead Publishing Limited, 2010
   73   74   75   76   77   78   79   80   81   82   83